期刊文献+

胃癌患者癌组织与血浆中miR-195的表达及临床病理意义 被引量:2

Expression of miR-195 and its clinicopathological significance in patients with gastric carcinoma
下载PDF
导出
摘要 目的:研究miR-195在胃癌患者癌组织与血浆中的表达及其与临床病理特征的关系。方法:采用实时荧光定量PCR(qRT-PCR)检测47例胃癌患者肿瘤组织与对应癌旁正常组织中miR-195的表达水平,以及相应47例胃癌患者术前血浆与10例健康者血浆中miR-195的表达水平,并分析其与临床病理特征的关系。结果:与癌旁正常组织相比,胃癌组织中miR-195表达降低,且其表达与淋巴结转移相关(P<0.05),与性别、年龄、TNM分期、肿瘤分化程度无关(P>0.05);与健康者相比,胃癌患者血浆中miR-195表达降低,且其表达与淋巴结转移相关(P<0.05),与性别、年龄、TNM分期、肿瘤分化程度无关(P>0.05)。结论:miR-195在胃癌患者癌组织及术前血浆中表达降低,且可能与淋巴结转移相关。 Objective: To investigate the association between miR-195 expression and clinicopatholog- ical features in tissues and plasma of patients with gastric cancer. Methods: Quantitative real-time PCR was used to detect the miR-195 expression levels in tumor tissues and normal gastric tissues of 47 patients with stomach cancer, as well as in plasma of 47 patients with gastric cancer and 10 healthy people, and investigated the association between the miR-195 expression and the clinicopathological features. Re- suits: Compared with the adjacent normal tissues, the cancerous tissues presented down-regulation of miR-195 expression, which was correlated with lymph node metastasis (P 〈 0.05 ), but not correlated with gender, age, TNM stage, or the degree of tumor differentiation. Compared with the healthy popula- tion, the patients with gastric cancer presented down-regulation of miR-195 expression in plasma, which was correlated with lymph node metastasis ( P 〈 0.05 ), and not correlated with gender, age, TNM stage, or the degree of tumor differentiation. The more lymph node metastasis, the lower expression of miR-195 in patients with gastric cancer. Conclusion: The expressions of miR-195 in tissues and plasma of pa- tients with gastric cancer were significantly decreased, which may be correlated with lymph node metastasis.
出处 《江苏大学学报(医学版)》 CAS 2016年第3期249-253,共5页 Journal of Jiangsu University:Medicine Edition
基金 新疆维吾尔自治区自然科学基金资助项目(2013211A090)
关键词 miR-195 胃癌 淋巴结转移 miR-195 gastric cancer lymph node metastasis
  • 相关文献

参考文献15

  • 1Lee SY, Oh SC. Changing strategies for target therapy in gastric cancer [ J 1. World J Gastroenterol, 2016, 22 (3): 1179 -1189.
  • 2Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015 [J]. CA Cancer J Clin, 2015, 65(1):5 -29.
  • 3Umemura T, Kuroki C. Circulating microRNAs as bio- markers of colorectal cancer [ J ]. Rinsho Byori, 2015, 63(3) :336-346.
  • 4Wong TS, Liu XB, Wong BY, et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carci- noma of tongue [ J ]. Clin Cancer Res, 2008,14 ( 9 ) : 2588 - 2592.
  • 5Flavin R J, Smyth PC, Laios A, et al. Potentially impor- tam microRNA cluster on chromosome 17p13.1 in pri- mary peritoneal carcinoma [ J ]. Mod Pathol, 2009, 22 (2) :197 -205.
  • 6Soon PS, Tacon LJ, Gill AJ, et al. miR-195 and miR- 483-5p identified as predictors of poor prognosis in adre- nocortical cancer [ J ]. Clin Cancer Res, 2009, 15 (24) :7684 - 7692.
  • 7Ding J, Huang S, Wang Y, et al. Genome-wide screen- ing reveals that miR-195 targets the TNF-o./NF-KB pathway by down-regulating IKB kinase et and TAB3 in hepatocellular carcinoma [ J ]. Hepatology, 2013, 58 (2) :654 - 666.
  • 8Zhao FL, Dou YC, Wang XF, et al. Serum microRNA- 195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer [ J ]. Mol Biol Rep, 2014, 41(9) :5913 -5922.
  • 9Dong L, Bi KH, Huang N, et al. Biological analysis of chronic lymphocytic leukemia: integration of mRNA and microRNA expression profiles [ J ]. Genet Mol Res, 2016,15 ( 1 ).
  • 10王江峰,凌志强,毛伟敏.microRNA-195在食管鳞状上皮细胞癌中的表达及临床意义[J].浙江医学,2014,36(4):281-284. 被引量:1

二级参考文献27

  • 1Ahmedin Jemal, Freddie Bray, Melissa M,et al. Global Cancer Statistics[J]. Ca Cancer J Clin,2011,61(2):69-90.
  • 2Jemal A, Center M M, Desantis C, et al. Global patterns of can- cer incidence and mortality rates and trends[J]. Cancer Epi- demiol Biomarkers Prev, 2010,19(2): 1893-1907.
  • 3Griffiths-Jones S. The microRNA Registry[J]. Nucleic Acids Res, 2004,32(Database issue):D109-11.
  • 4Zhang H, Li Y, Lai M.The microRNA network and tumor metasta- sis[J].Qncogene, 2010, 29(7):937-948.
  • 5Schee K, Boye K, Abrahamsen T W, et al. Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in coLorectal cancer[J].BMC Cancer, 2012, 12(2):505.
  • 6Santarpia L, Nicoloso M, Calin G A. MicroRNAs! a complex reg- ulatory network drives the acquisition of malignant cell phenotype [J].Endocr Relat Cancer, 2010, 17(1 ):F51-75.
  • 7Wang R, Zhao N, Li S, et aI.MicroRNA-195 suppresses anglo- genesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42[J]. Hepatology, 2013, 58(2):642-653.
  • 8Xu T, Zhu Y, Xiong Y, et al. MicroRNA-195 suppresses tumori- genicity and regulates G1/S transition of human hepatocellular carcinoma cells[J]. Hepatology, 2009, 50(1):113-121.
  • 9Fu M G, Li S, Yu T T, et al. Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42[J]. FEBS Lett, 2013,587(21 ):3471-3479.
  • 10Nakao M, Yano E. A comparative study of behavioural, physical and mental health status between term-limited and tenure- tracking employees in a population of Japanese male re- searchers[J].Public Health, 2006,120(4):373-379.

共引文献6

同被引文献31

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部